<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">exposure </span>
   <span class="font30">PTSD </span>
   <span class="font29">treatment </span>
   <span class="font22">MDMA </span>
   <span class="font22">effects </span>
   <span class="font21">therapy </span>
   <span class="font20">DCS </span>
   <span class="font20">enhancement </span>
   <span class="font20">patients </span>
   <span class="font18">studies </span>
   <span class="font18">propranolol </span>
   <span class="font18">extinction </span>
   <span class="font18">clinical </span>
   <span class="font16">participants </span>
   <span class="font16">sessions </span>
   <span class="font16">hydrocortisone </span>
   <span class="font16">placebo </span>
   <span class="font15">disorder </span>
   <span class="font15">enhanced </span>
   <span class="font15">stress </span>
   <span class="font14">prior </span>
   <span class="font14">fear </span>
   <span class="font14">received </span>
   <span class="font14">session </span>
   <span class="font14">exposure-based </span>
   <span class="font14">memory </span>
   <span class="font14">posttraumatic </span>
   <span class="font14">randomized </span>
   <span class="font14">{border-style </span>
   <span class="font13">Psychiatry </span>
   <span class="font13">learning </span>
   <span class="font13">colleagues </span>
   <span class="font13">pharmacological </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">blood </span>
   <span class="font13">study </span>
   <span class="font13">enhance </span>
   <span class="font13">group </span>
   <span class="font13">symptoms </span>
   <span class="font13">trials </span>
   <span class="font13">minutes </span>
   <span class="font13">reconsolidation </span>
   <span class="font13">trial </span>
   <span class="font12">administration </span>
   <span class="font12">adverse </span>
   <span class="font12">efficacy </span>
   <span class="font12">CAPS </span>
   <span class="font12">trauma </span>
   <span class="font12">traumatic </span>
   <span class="font12">Psychopharmacology </span>
   <span class="font12">anxiety </span>
   <span class="font12">augmentation </span>
   <span class="font12">beneficial </span>
   <span class="font12">given </span>
   <span class="font12">oxytocin </span>
   <span class="font12">prolonged </span>
   <span class="font12">research </span>
   <span class="font12">showed </span>
   <span class="font12">Clinical </span>
   <span class="font12">D-cycloserine </span>
   <span class="font12">cognitive </span>
   <span class="font12">compared </span>
   <span class="font12">controlled </span>
   <span class="font12">enhancers </span>
   <span class="font12">evidence </span>
   <span class="font12">outcome </span>
   <span class="font12">psychotherapy </span>
   <span class="font12">sessions. </span>
   <span class="font12">trials, </span>
   <span class="font12">use </span>
   <span class="font12">used </span>
   <span class="font12">Placebo: </span>
   <span class="font12">Propranolol </span>
   <span class="font12">different </span>
   <span class="font12">doses </span>
   <span class="font12">drug </span>
   <span class="font12">points </span>
   <span class="font12">review </span>
   <span class="font11">Kleine </span>
   <span class="font11">Neuroscience </span>
   <span class="font11">alcohol </span>
   <span class="font11">dose </span>
   <span class="font11">examined </span>
   <span class="font11">hours </span>
   <span class="font11">i.e., </span>
   <span class="font11">patients. </span>
   <span class="font11">response </span>
   <span class="font11">van </span>
   <span class="font11">women, </span>
   <span class="font11">working </span>
   <span class="font11">Brunet </span>
   <span class="font11">Civilian, </span>
   <span class="font11">However, </span>
   <span class="font11">Hydrocortisone </span>
   <span class="font11">Litz </span>
   <span class="font11">Mithoefer </span>
   <span class="font11">PTSD. </span>
   <span class="font11">Psychiatric </span>
   <span class="font11">Rothbaum </span>
   <span class="font11">Self-report </span>
   <span class="font11">consolidation </span>
   <span class="font11">d-cycloserine </span>
   <span class="font11">disorders </span>
   <span class="font11">effect </span>
   <span class="font11">enhancer </span>
   <span class="font11">findings </span>
   <span class="font11">heart </span>
   <span class="font11">lower </span>
   <span class="font11">medication </span>
   <span class="font11">mixed </span>
   <span class="font11">new </span>
   <span class="font11">patients, </span>
   <span class="font11">px; </span>
   <span class="font11">receive </span>
   <span class="font11">scores </span>
   <span class="font11">significant </span>
   <span class="font11">time√ógroup </span>
   <span class="font11">{font-family </span>
   <span class="font11">American </span>
   <span class="font11">Biological </span>
   <span class="font11">Foa </span>
   <span class="font11">Participants </span>
   <span class="font11">Pretreatment: </span>
   <span class="font11">RCT; </span>
   <span class="font11">Ressler </span>
   <span class="font11">Traumatic </span>
   <span class="font11">account </span>
   <span class="font11">administered </span>
   <span class="font11">chronic </span>
   <span class="font11">decline </span>
   <span class="font11">excluded </span>
   <span class="font11">favor </span>
   <span class="font11">font-size </span>
   <span class="font11">good </span>
   <span class="font11">group. </span>
   <span class="font11">higher </span>
   <span class="font11">imaginal </span>
   <span class="font11">levels </span>
   <span class="font11">provided </span>
   <span class="font11">psychotropic </span>
   <span class="font11">related </span>
   <span class="font11">retrieval </span>
   <span class="font11">self-reported </span>
   <span class="font11">session, </span>
   <span class="font11">symptom </span>
   <span class="font11">symptoms. </span>
   <span class="font11">therapy. </span>
   <span class="font11">(e.g., </span>
   <span class="font11">(i.e., </span>
   <span class="font11">Further, </span>
   <span class="font11">MDMA, </span>
   <span class="font11">MDMA: </span>
   <span class="font11">Minnen </span>
   <span class="font11">N=) </span>
   <span class="font11">Quervain </span>
   <span class="font11">Research </span>
   <span class="font11">Rothbaum, </span>
   <span class="font11">Yehuda </span>
   <span class="font11">avoidance </span>
   <span class="font11">cardiovascular </span>
   <span class="font11">discussion </span>
   <span class="font11">double; </span>
   <span class="font11">early </span>
   <span class="font11">effective </span>
   <span class="font11">effects, </span>
   <span class="font11">experimental </span>
   <span class="font11">following </span>
   <span class="font11">humans </span>
   <span class="font11">improve </span>
   <span class="font11">information </span>
   <span class="font11">mg/kg </span>
   <span class="font11">oral </span>
   <span class="font11">placebo-controlled </span>
   <span class="font11">potential </span>
   <span class="font11">processes </span>
   <span class="font11">propranolol, </span>
   <span class="font11">psychological </span>
   <span class="font11">reviewed </span>
   <span class="font11">sessions, </span>
   <span class="font11">specific </span>
   <span class="font11">subjective </span>
   <span class="font11">trauma, </span>
   <span class="font11">written </span>
   <span class="font11">(N=) </span>
   <span class="font11">(de </span>
   <span class="font11">(see </span>
   <span class="font11">,-methylenedioxymethamphetamine </span>
   <span class="font11">DCS: </span>
   <span class="font11">Pharmacological </span>
   <span class="font11">Posttreatment: </span>
   <span class="font11">Psychology </span>
   <span class="font11">abuse </span>
   <span class="font11">addition </span>
   <span class="font11">administration, </span>
   <span class="font11">baseline </span>
   <span class="font11">better </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">case </span>
   <span class="font11">conditioned </span>
   <span class="font11">considered </span>
   <span class="font11">contra-indications </span>
   <span class="font11">cortisol </span>
   <span class="font11">criteria </span>
   <span class="font11">date, </span>
   <span class="font11">did </span>
   <span class="font11">differences </span>
   <span class="font11">effect, </span>
   <span class="font11">emotional </span>
   <span class="font11">especially </span>
   <span class="font11">exposure, </span>
   <span class="font11">future </span>
   <span class="font11">high </span>
   <span class="font11">human </span>
   <span class="font11">index </span>
   <span class="font11">interesting </span>
   <span class="font11">large </span>
   <span class="font11">low </span>
   <span class="font11">mechanism </span>
   <span class="font11">minutes); </span>
   <span class="font11">open-label </span>
   <span class="font11">orally </span>
   <span class="font11">paired </span>
   <span class="font11">placebo, </span>
   <span class="font11">placebo. </span>
   <span class="font11">process </span>
   <span class="font11">proportion </span>
   <span class="font11">protocol </span>
   <span class="font11">reactivation; </span>
   <span class="font11">responses </span>
   <span class="font11">results </span>
   <span class="font11">routine </span>
   <span class="font11">script </span>
   <span class="font11">sertraline </span>
   <span class="font11">session. </span>
   <span class="font11">severe </span>
   <span class="font11">skin </span>
   <span class="font11">solid; </span>
   <span class="font11">studies, </span>
   <span class="font11">study, </span>
   <span class="font11">suffering </span>
   <span class="font11">time </span>
   <span class="font11">treated </span>
   <span class="font11">upcoming </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(Foa </span>
   <span class="font10">Discussion </span>
   <span class="font10">Dosing, </span>
   <span class="font10">General </span>
   <span class="font10">Kindt </span>
   <span class="font10">MDMA. </span>
   <span class="font10">New </span>
   <span class="font10">Oehen </span>
   <span class="font10">Proposed </span>
   <span class="font10">Propranolol: </span>
   <span class="font10">Psychological </span>
   <span class="font10">Reflecting </span>
   <span class="font10">Ressler, </span>
   <span class="font10">Richardson </span>
   <span class="font10">SSRI's </span>
   <span class="font10">Suris </span>
   <span class="font10">[], </span>
   <span class="font10">amygdala </span>
   <span class="font10">animal </span>
   <span class="font10">appear </span>
   <span class="font10">appears </span>
   <span class="font10">approximately </span>
   <span class="font10">bold </span>
   <span class="font10">care </span>
   <span class="font10">commonly </span>
   <span class="font10">condition. </span>
   <span class="font10">conductance </span>
   <span class="font10">courier; </span>
   <span class="font10">decrease </span>
   <span class="font10">dosed </span>
   <span class="font10">effects. </span>
   <span class="font10">em; </span>
   <span class="font10">enhancement, </span>
   <span class="font10">event </span>
   <span class="font10">events </span>
   <span class="font10">exclusion </span>
   <span class="font10">follow-up </span>
   <span class="font10">half-life </span>
   <span class="font10">hydrocortisone, </span>
   <span class="font10">immediately </span>
   <span class="font10">important </span>
   <span class="font10">improvement </span>
   <span class="font10">including </span>
   <span class="font10">increased </span>
   <span class="font10">integration </span>
   <span class="font10">learning. </span>
   <span class="font10">major </span>
   <span class="font10">male, </span>
   <span class="font10">manual </span>
   <span class="font10">mechanisms </span>
   <span class="font10">medication, </span>
   <span class="font10">memories </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">mg, </span>
   <span class="font10">overall </span>
   <span class="font10">paroxetine </span>
   <span class="font10">physical </span>
   <span class="font10">pilot </span>
   <span class="font10">populations </span>
   <span class="font10">post-traumatic </span>
   <span class="font10">proposed </span>
   <span class="font10">proven </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">question </span>
   <span class="font10">rate </span>
   <span class="font10">reactivation </span>
   <span class="font10">reduce </span>
   <span class="font10">regular </span>
   <span class="font10">reported </span>
   <span class="font10">resulted </span>
   <span class="font10">short-acting </span>
   <span class="font10">shown </span>
   <span class="font10">subsequent </span>
   <span class="font10">suggest </span>
   <span class="font10">supplementary </span>
   <span class="font10">synthesis </span>
   <span class="font10">therapeutic </span>
   <span class="font10">treatment. </span>
   <span class="font10">underlying </span>
  </p>
 </body>
</html>
